Wenjie Chen

The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study

E. Kotlyar, Yusi Chen, Jiang Li, 2022, Frontiers in Pharmacology.

miR‐103a‐2‐5p/miR‐30c‐1‐3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7

Wenjie Chen, Keqin Zhou, Gan Yao, 2019, Journal of cellular biochemistry.

Effect of multidisciplinary team (MDT) centred on pregnant women with pulmonary hypertension on treatment and outcomes of pregnancy

Jiang Li, Yusi Chen, Jun Luo, 2023, BMC Pulmonary Medicine.

Successful Eisenmenger syndrome‐targeted drug therapy in pregnant women: a case series and literature review

Jiang Li, Yusi Chen, Jun Luo, 2023, BJOG : an international journal of obstetrics and gynaecology.

Differential expression spectrum and targeted gene prediction of tRNA-derived small RNAs in idiopathic pulmonary arterial hypertension

Jiang Li, Yusi Chen, Jun Luo, 2023, Frontiers in molecular biosciences.

Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)

Jiang Li, Yusi Chen, Jun Luo, 2023, Frontiers in pharmacology.

Analysis of relationship between P wave dispersion and diagnosis of pulmonary arterial hypertension and risk stratification.

Jiang Li, Yusi Chen, Jun Luo, 2023, Journal of Electrocardiology.